Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Sales (2023 - 2025)

Historic Return on Sales for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 90.43%.

  • Mangoceuticals' Return on Sales fell 754400.0% to 90.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 42.46%, marking a year-over-year decrease of 301000.0%. This contributed to the annual value of 14.14% for FY2024, which is 15400.0% down from last year.
  • According to the latest figures from Q3 2025, Mangoceuticals' Return on Sales is 90.43%, which was down 754400.0% from 32.22% recorded in Q2 2025.
  • Over the past 5 years, Mangoceuticals' Return on Sales peaked at 7.34% during Q3 2023, and registered a low of 90.43% during Q3 2025.
  • Moreover, its 3-year median value for Return on Sales was 16.17% (2023), whereas its average is 25.96%.
  • As far as peak fluctuations go, Mangoceuticals' Return on Sales surged by 143700bps in 2024, and later plummeted by -754400bps in 2025.
  • Over the past 3 years, Mangoceuticals' Return on Sales (Quarter) stood at 10.51% in 2023, then plummeted by -76bps to 18.51% in 2024, then plummeted by -388bps to 90.43% in 2025.
  • Its Return on Sales stands at 90.43% for Q3 2025, versus 32.22% for Q2 2025 and 44.27% for Q1 2025.